Australia's most trusted
source of pharma news
Wednesday, 20 August 2025
Posted 20 August 2025 AM
Two new drugs could be added to the PBS from next month, as well as new forms of already subsidised medicines recommended by the reimbursement committee roughly three years ago.
AstraZeneca’s breast cancer drug Truqap, which secured the PBAC’s recommendation in March is currently sitting in the last stage before listing occurs, known as the government processes stage.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.